{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T05:05:42Z","timestamp":1731819942763,"version":"3.28.0"},"reference-count":37,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2024,10,31]]},"DOI":"10.5582\/ddt.2024.01064","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T22:10:16Z","timestamp":1729721416000},"page":"290-295","source":"Crossref","is-referenced-by-count":0,"title":["Histopathological analysis of filament formation of &lt;i&gt;Nocardia farcinica&lt;\/i&gt; in a silkworm infection model"],"prefix":"10.5582","volume":"18","author":[{"given":"Koki","family":"Iwata","sequence":"first","affiliation":[{"name":"Graduate School of Clinical Technology, Tokyo University of Technology, Tokyo, Japan."},{"name":"Department of RNA Pathobiology and Therapeutics, Meiji Pharmaceutical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Public Health &amp; Division of Medical Education, Juntendo University Graduate School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Sekimizu","sequence":"additional","affiliation":[{"name":"Drug Discoveries by Silkworm Models, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan."},{"name":"Genome Pharmaceuticals Institute, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Graduate School of Clinical Technology, Tokyo University of Technology, Tokyo, Japan."},{"name":"Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Brown-Elliott BA, Brown JM, Conville PS, Wallace Jr RJ. Clinical and laboratory features of the <i>Nocardia<\/i> spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006; 19:259-282.","key":"1","DOI":"10.1128\/CMR.19.2.259-282.2006"},{"doi-asserted-by":"crossref","unstructured":"2. Budzik JM, Hosseini M, Mackinnon Jr AC, Taxy JB. Disseminated <i>Nocardia farcinica<\/i>: literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt). 2012; 13:163-170.","key":"2","DOI":"10.1089\/sur.2011.012"},{"doi-asserted-by":"crossref","unstructured":"3. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, V\u00e1zquez G. Infection caused by <i>Nocardia farcinica<\/i>: case report and review. Eur J Clin Microbiol Infect Dis. 2000; 19:205-212.","key":"3","DOI":"10.1007\/s100960050460"},{"doi-asserted-by":"crossref","unstructured":"4. Tamarit M, Poveda P, Bar\u00f3n M, Del Pozo JM. Four cases of nocardial brain abscess. Surg Neurol Int. 2012; 3:88.","key":"4","DOI":"10.4103\/2152-7806.99927"},{"doi-asserted-by":"crossref","unstructured":"5. Lerner PI. Nocardiosis. Clin Infect Dis. 1996; 22:891-905.","key":"5","DOI":"10.1093\/clinids\/22.6.891"},{"doi-asserted-by":"crossref","unstructured":"6. Lee EK, Kim J, Park DH, Lee CK, Kim SB, Sohn JW, Yoon YK. Disseminated nocardiosis caused by <i>Nocardia farcinica<\/i> in a patient with colon cancer: a case report and literature review. Medicine (Baltimore). 2021; 100:e26682.","key":"6","DOI":"10.1097\/MD.0000000000026682"},{"doi-asserted-by":"crossref","unstructured":"7. Koenig S, Mehlich AM, Ackermann D, Hamid ME, Saeed NS, Mukhtar M, El Hassan M. Homologous housekeeping proteins in <i>Nocardia<\/i>--the NoDaMS proteomic database. Front Biosci. 2008; 13:842-855.","key":"7","DOI":"10.2741\/2725"},{"doi-asserted-by":"crossref","unstructured":"8. Ishikawa J, Yamashita A, Mikami Y, Hoshino Y, Kurita H, Hotta K, Shiba T, Hattori M. The complete genomic sequence of <i>Nocardia farcinica<\/i> IFM 10152. Proc Natl Acad Sci U S A. 2004; 101:14925-14930.","key":"8","DOI":"10.1073\/pnas.0406410101"},{"doi-asserted-by":"crossref","unstructured":"9. Nathar S, Rajmichael R, Jeyaraj Pandian C, Nagarajan H, Mathimaran A, Kingsley JD, Jeyaraman J. Exploring Nocardia&apos;s ecological spectrum and novel therapeutic frontiers through whole-genome sequencing: unraveling drug resistance and virulence factors. Arch Microbiol. 2024; 206:76.","key":"9","DOI":"10.1007\/s00203-023-03799-z"},{"doi-asserted-by":"crossref","unstructured":"10. Desmond EP, Flores M. Mouse pathogenicity studies of <i>Nocardia asteroides<\/i> complex species and clinical correlation with human isolates. FEMS Microbiol Lett. 1993; 110:281-284.","key":"10","DOI":"10.1016\/0378-1097(93)90115-I"},{"doi-asserted-by":"crossref","unstructured":"11. McTaggart LR, Doucet J, Witkowska M, Richardson SE. Antimicrobial susceptibility among clinical <i>Nocardia<\/i> species identified by multilocus sequence analysis. Antimicrob Agents Chemother. 2015; 59:269-275.","key":"11","DOI":"10.1128\/AAC.02770-14"},{"doi-asserted-by":"crossref","unstructured":"12. Goodwin FK. From the alcohol, drug abuse, and mental health administration. JAMA. 1991; 266:1056.","key":"12","DOI":"10.1001\/jama.1991.03470080026004"},{"doi-asserted-by":"crossref","unstructured":"13. Kaito C, Murakami K, Imai L, Furuta K. Animal infection models using non-mammals. Microbiol Immunol. 2020; 64:585-592.","key":"13","DOI":"10.1111\/1348-0421.12834"},{"doi-asserted-by":"crossref","unstructured":"14. Cheluvappa R, Scowen P, Eri R. Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation. Pharmacol Res Perspect. 2017; 5:e00332.","key":"14","DOI":"10.1002\/prp2.332"},{"doi-asserted-by":"crossref","unstructured":"15. Ahlawat S, Sharma KK. Lepidopteran insects: emerging model organisms to study infection by enteropathogens. Folia Microbiol (Praha). 2023; 68:181-196.","key":"15","DOI":"10.1007\/s12223-022-01014-y"},{"doi-asserted-by":"crossref","unstructured":"16. M\u00e9nard G, Rouillon A, Cattoir V, Donnio PY. <i>Galleria mellonella<\/i> as a suitable model of bacterial infection: past, present and future. Front Cell Infect Microbiol. 2021; 11:782733.","key":"16","DOI":"10.3389\/fcimb.2021.782733"},{"doi-asserted-by":"crossref","unstructured":"17. Panthee S, Paudel A, Hamamoto H, Sekimizu K. Advantages of the silkworm as an animal model for developing novel antimicrobial agents. Front Microbiol. 2017; 8:373.","key":"17","DOI":"10.3389\/fmicb.2017.00373"},{"doi-asserted-by":"crossref","unstructured":"18. Matsumoto Y, Fukano H, Hasegawa N, Hoshino Y, Sugita T. Quantitative evaluation of <i>Mycobacterium abscessus<\/i> clinical isolate virulence using a silkworm infection model. PLoS One. 2022; 17:e0278773.","key":"18","DOI":"10.1371\/journal.pone.0278773"},{"doi-asserted-by":"crossref","unstructured":"19. Paudel A, Furuta Y, Higashi H. Silkworm model for <i>Bacillus anthracis<\/i> infection and virulence determination. Virulence. 2021; 12:2285-2295.","key":"19","DOI":"10.1080\/21505594.2021.1965830"},{"doi-asserted-by":"crossref","unstructured":"20. Majima H, Arai T, Kamei K, Watanabe A. <i>In vivo<\/i> efficacy of pitavastatin combined with itraconazole against <i>Aspergillus fumigatus<\/i> in silkworm models. Microbiol Spectr. 2023; 11:e0266623.","key":"20","DOI":"10.1128\/spectrum.02666-23"},{"doi-asserted-by":"crossref","unstructured":"21. Ishii M, Matsumoto Y, Sekimizu K. Usefulness of silkworm as a host animal for understanding pathogenicity of <i>Cryptococcus neoformans<\/i>. Drug Discov Ther. 2016; 10:9-13.","key":"21","DOI":"10.5582\/ddt.2016.01015"},{"doi-asserted-by":"crossref","unstructured":"22. Mikami K, Sonobe K, Ishino K, Noda T, Kato M, Hanao M, Hamamoto H, Sekimizu K, Okazaki M. Evaluation of pathogenicity and therapeutic effectiveness of antibiotics using silkworm <i>Nocardia<\/i> infection model. Drug Discov Ther. 2021; 15:73-77.","key":"22","DOI":"10.5582\/ddt.2021.01035"},{"doi-asserted-by":"crossref","unstructured":"23. Suehiro Y, Nomura R, Matayoshi S, Otsugu M, Iwashita N, Nakano K. Evaluation of the collagen-binding properties and virulence of killed <i>Streptococcus mutans<\/i> in a silkworm model. Sci Rep. 2022; 12:2800.","key":"23","DOI":"10.1038\/s41598-022-06345-x"},{"doi-asserted-by":"crossref","unstructured":"24. Matsumoto Y, Fukano H, Katano H, Hoshino Y, Sugita T. Histopathological analysis revealed that <i>Mycobacterium abscessus<\/i> proliferates in the fat bodies of silkworms. Drug Discov Ther. 2023; 17:139-143.","key":"24","DOI":"10.5582\/ddt.2023.01014"},{"doi-asserted-by":"crossref","unstructured":"25. Beaman BL. Structural and biochemical alterations of <i>Nocardia asteroides<\/i> cell walls during its growth cycle. J Bacteriol. 1975; 123:1235-1253.","key":"25","DOI":"10.1128\/jb.123.3.1235-1253.1975"},{"doi-asserted-by":"crossref","unstructured":"26. Beaman BL, Shankel DM. Ultrastructure of <i>Nocardia<\/i> cell growth and development on defined and complex agar media. J Bacteriol. 1969; 99:876-884.","key":"26","DOI":"10.1128\/jb.99.3.876-884.1969"},{"unstructured":"27. Audenaert E, Almafragi A, Vuylsteke M, Verdonckt C, Verdonk R. <i>Nocardia farcinica<\/i> arthritis of the knee. A case report. Acta Orthop Belg. 2004; 70:386-388.","key":"27"},{"unstructured":"28. Thakur A, Eapen J, Cherian SS. Septic arthritis by <i>Nocardia farcinica<\/i>: case report and literature review.","key":"28"},{"doi-asserted-by":"crossref","unstructured":"29. Han L, Ji X, Liu X, Xu S, Li F, Che Y, Qiu X, Sun L, Li Z. Estradiol aggravate <i>Nocardia farcinica<\/i> infections in mice. Front Immunol. 2022; 13:858609.","key":"29","DOI":"10.3389\/fimmu.2022.858609"},{"doi-asserted-by":"crossref","unstructured":"30. Beaman BL, Beaman L. <i>Nocardia<\/i> species: host-parasite relationships. Clin Microbiol Rev. 1994; 7:213-264.","key":"30","DOI":"10.1128\/CMR.7.2.213"},{"doi-asserted-by":"crossref","unstructured":"31. Beaman BL. Interaction of <i>Nocardia asteroides<\/i> at different phases of growth with <i>in vitro<\/i>-maintained macrophages obtained from the lungs of normal and immunized rabbits. Infect Immun. 1979; 26:355-361.","key":"31","DOI":"10.1128\/iai.26.1.355-361.1979"},{"doi-asserted-by":"crossref","unstructured":"32. Beaman BL, Maslan S. Virulence of <i>Nocardia asteroides<\/i> during its growth cycle. Infect Immun. 1978; 20:290-295.","key":"32","DOI":"10.1128\/iai.20.1.290-295.1978"},{"doi-asserted-by":"crossref","unstructured":"33. Beaman BL, Sugar AM. <i>Nocardia<\/i> in naturally acquired and experimental infections in animals. J Hyg (Lond). 1983; 91:393-419.","key":"33","DOI":"10.1017\/S0022172400060447"},{"doi-asserted-by":"crossref","unstructured":"34. Thakur A, Eapen J, Cherian SS. Septic arthritis by <i>Nocardia farcinica<\/i>: case report and literature review. IDCases. 2022; 31:e01668.","key":"34","DOI":"10.1016\/j.idcr.2022.e01668"},{"doi-asserted-by":"crossref","unstructured":"35. Gao S, Liu Q, Zhou X, Dai X, He H. Primary cutaneous nocardiosis due to <i>Nocardia farcinica<\/i>: a case report of an often overlooked infection. Infect Drug Resist. 2021; 14:1435-1440.","key":"35","DOI":"10.2147\/IDR.S306161"},{"doi-asserted-by":"crossref","unstructured":"36. Bittar F, Stremler N, Audi\u00e9 JP, Dubus JC, Sarles J, Raoult D, Rolain JM. <i>Nocardia farcinica<\/i> lung infection in a patient with cystic fibrosis: a case report. J Med Case Rep. 2010; 4:84.","key":"36","DOI":"10.1186\/1752-1947-4-84"},{"doi-asserted-by":"crossref","unstructured":"37. Takamatsu A, Yaguchi T, Tagashira Y, Watanabe A, Honda H; Japan Nocardia Study Group. Nocardiosis in Japan: a multicentric retrospective cohort study. Antimicrob Agent Chemother. 2022; 15:e0189021.","key":"37","DOI":"10.1128\/aac.01890-21"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/5\/18_2024.01064\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T04:26:05Z","timestamp":1731731165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/5\/18_2024.01064\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2024.01064","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"type":"print","value":"1881-7831"},{"type":"electronic","value":"1881-784X"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"article-number":"2024.01064"}}